Correlation analysis showed that m6A levels in CD68+ cells, m6A modification of SLC15A3, and SLC15A3 mRNA levels were all positively correlated with psoriasis severity, as measured by the Psoriasis Area and Severity Index (PASI) (Figure 7E). This evidence concerns the gene SLC15A3 and psoriasis.